Compare CVM & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVM | FOFO |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | 14 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 19.0M |
| IPO Year | 1996 | N/A |
| Metric | CVM | FOFO |
|---|---|---|
| Price | $1.37 | $3.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 449.5K | 152.4K |
| Earning Date | 05-13-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,033.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | ★ 65.45 | N/A |
| 52 Week Low | $0.89 | $1.75 |
| 52 Week High | $13.48 | $68.00 |
| Indicator | CVM | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 47.94 |
| Support Level | $0.95 | $2.55 |
| Resistance Level | $1.59 | $5.74 |
| Average True Range (ATR) | 0.12 | 0.46 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 80.10 | 18.69 |
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.